Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001780656 | SCV002024398 | likely pathogenic | Ataxia-telangiectasia syndrome | 2021-11-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001780656 | SCV003337851 | pathogenic | Ataxia-telangiectasia syndrome | 2022-03-23 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 1323951). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with ATM-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asp1725Argfs*24) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). |
Center for Genomic Medicine, |
RCV001780656 | SCV004809889 | likely pathogenic | Ataxia-telangiectasia syndrome | 2024-04-04 | criteria provided, single submitter | clinical testing |